Abstract
The principle of constructing heterobifunctional molecules using the classical AMP-activated protein kinase inhibitor dorsomorphin is discussed. Based on computer modeling data, a structural modification of dorsomorphin targeting the MDR1 membrane protein is proposed. Three new PROTAC-type structures, differing in the length of the linker based on ω-amino acids, were designed and synthesized to induce ubiquitin-dependent proteolysis of MDR1.

This publication has 33 references indexed in Scilit: